Empagliflozin for the treatment of nonalcoholic steatohepatitis in patients with type 2 diabetes mellitus
Background and Aims Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a novel class of drugs that lower glucose by inducing renal glycosuria. We aimed to explore whether SGLT2 inhibitor added to the usual care for patients with type 2 diabetes mellitus (T2DM) and biopsy-proven nonalcoholic steat...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Published: |
Springer
2020
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/36924/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|